Regeneron Pharmaceuticals Stock Price

0.00 (0.0%)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.00 0.0% 624.52 0.00 0.00 0.00 624.52 06:38:01
Bid Price Ask Price Spread Spread % News
625.00 632.00 7.00 1.11% - -
Stock Trades Traded Volume Average Volume 52 Week Range
3 13 901,403 271.37 - 680.00
Last Trade Time Type Quantity Stock Price Currency
06:38:01 1 $ 628.00 USD

Regeneron Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 64.07B 102.60M 73.01M $ 7.86B $ 2.71B 18.45 31.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Regeneron Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical REGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week625.72680.00618.0001634.78705,836-1.20-0.19%
1 Month648.00680.00596.015632.13695,533-23.48-3.62%
3 Months577.18680.00522.02600.681,225,94747.348.2%
6 Months385.53680.00372.16533.261,291,853238.9961.99%
1 Year304.48680.00271.37459.511,005,404320.04105.11%
3 Years468.71680.00271.37403.30858,778155.8133.24%
5 Years593.66680.00271.37412.88850,16330.865.2%

Regeneron Pharmaceuticals Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.